Table 2:
All cisgender women (N=1431) |
Cisgender women meeting CDC indications for PrEP (N=84) |
|||||
---|---|---|---|---|---|---|
n | % | AOR | 95% CI | n | % | |
Year | ||||||
2013 | 32 | 13.9 | Ref | 1 | 5.9 | |
2014 | 63 | 17.8 | 1.34 | 0.84 to 2.15 | 7 | 25.0 |
2015 | 64 | 16.0 | 1.18 | 0.74 to 1.88 | 5 | 26.3 |
2016 | 77 | 17.3 | 1.31 | 0.83 to 2.07 | 6 | 30.0 |
Race/Ethnicity | ||||||
Non-Hispanic White | 127 | 20.7 | Ref | 11 | 22.5 | |
Non-Hispanic Black | 33 | 13.8 | 0.59 | 0.39 – 0.89 | 1 | * |
Hispanic/Latino | 42 | 11.0 | 0.46 | 0.31 – 0.66 | 2 | 10.5 |
Other/Unknown | 34 | 17.3 | 0.78 | 0.51 – 1.19 | 5 | 41.7 |
Age group | ||||||
18–24 | 103 | 15.3 | Ref | 5 | 21.7 | |
25–34 | 94 | 20.4 | 1.38 | 1.01 – 1.88 | 5 | 19.2 |
35–54 | 35 | 13.4 | 0.79 | 0.52 – 1.20 | 9 | 28.1 |
55+ | 4 | 11.1 | 0.59 | 0.21 – 1.67 | 0 | * |
PrEP – pre-exposure prophylaxis; CDC – Centers for Disease Control and Prevention; AOR – adjusted odds ratio; CI – confidence interval
Not reported because of a sample size of fewer than 10 people. We did not evaluate PrEP awareness by demographic characteristics among women with CDC indications for PrEP due to the small sample size.